{"id":721903,"date":"2026-08-01T00:44:18","date_gmt":"2026-08-01T00:44:18","guid":{"rendered":"https:\/\/www.newsbeep.com\/uk\/721903\/"},"modified":"2026-08-01T00:44:18","modified_gmt":"2026-08-01T00:44:18","slug":"cancer-patient-becomes-worlds-first-to-receive-landmark-treatment","status":"publish","type":"post","link":"https:\/\/www.newsbeep.com\/uk\/721903\/","title":{"rendered":"Cancer patient becomes world\u2019s first to receive \u2018landmark\u2019 treatment"},"content":{"rendered":"<p>Your support helps us to tell the story<\/p>\n<p class=\"sc-1uza6dc-0 iOIawn\">From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it&#8217;s investigating the financials of Elon Musk&#8217;s pro-Trump PAC or producing our latest documentary, &#8216;The A Word&#8217;, which shines a light on the American women fighting for reproductive rights, we know how important it is to parse out the facts from the messaging.<\/p>\n<p class=\"sc-1uza6dc-0 iOIawn\">At such a critical moment in US history, we need reporters on the ground. Your donation allows us to keep sending journalists to speak to both sides of the story.<\/p>\n<p class=\"sc-1uza6dc-0 iOIawn\">The Independent is trusted by Americans across the entire political spectrum. And unlike many other quality news outlets, we choose not to lock Americans out of our reporting and analysis with paywalls. We believe quality journalism should be available to everyone, paid for by those who can afford it.<\/p>\n<p>Your support makes all the difference.Read more<\/p>\n<p>A woman with advanced <a href=\"https:\/\/www.independent.co.uk\/topic\/ovarian-cancer\" rel=\"nofollow noopener\" target=\"_blank\">ovarian cancer<\/a> has become the first patient globally to receive a pioneering new <a href=\"https:\/\/www.independent.co.uk\/topic\/therapy\" rel=\"nofollow noopener\" target=\"_blank\">therapy<\/a>. <\/p>\n<p>Tracy Tomlinson, 58, was given the experimental drug, ZI-MA4-1, at the Christie NHS Foundation Trust in Manchester.<\/p>\n<p>The <a href=\"https:\/\/www.independent.co.uk\/topic\/treatment\" rel=\"nofollow noopener\" target=\"_blank\">treatment<\/a> forms part of a clinical trial evaluating its efficacy for several <a href=\"https:\/\/www.independent.co.uk\/topic\/cancer\" rel=\"nofollow noopener\" target=\"_blank\">cancer<\/a> types, including ovarian, lung, sarcomas, and head and neck cancer. <\/p>\n<p>Led by the Christie, with a site also at the Royal Marsden in London, the study offers hope to many participants with few other options for survival.<\/p>\n<p>Mrs Tomlinson, from Chadderton in Greater Manchester, has already defied expectations, having undergone surgery and multiple rounds of <a href=\"https:\/\/www.independent.co.uk\/topic\/chemotherapy\" rel=\"nofollow noopener\" target=\"_blank\">chemotherapy<\/a> since her 2020 diagnosis.<\/p>\n<p>How the new therapy works<\/p>\n<p>The new therapy works by combining two powerful methods in fighting cancer.<\/p>\n<p>Firstly, it harnesses the body\u2019s natural killer (NK) <a href=\"https:\/\/www.independent.co.uk\/topic\/cells\" rel=\"nofollow noopener\" target=\"_blank\">cells<\/a>, which are specialist immune cells that destroy abnormal ones.<\/p>\n<p>Secondly, T-cell receptors (TCRs) on the cells are engineered to recognise and target tumours producing a protein called Mage-A4.<\/p>\n<p><img decoding=\"async\" src=\"https:\/\/www.newsbeep.com\/uk\/wp-content\/uploads\/2026\/08\/01KYS2MR7SCZ0TEW20QB14NXRZ.jpg\"  loading=\"lazy\" alt=\"Tracy Tomlinson has undergone surgery and several rounds of chemotherapy since she was diagnosed in 2020\" class=\"sc-1mc30lb-0 ggpMaE inline-gallery-btn\"\/>Tracy Tomlinson has undergone surgery and several rounds of chemotherapy since she was diagnosed in 2020 (PA)<\/p>\n<p>Mage-A4 is found in several types of cancer and <a href=\"https:\/\/www.independent.co.uk\/topic\/experts\" rel=\"nofollow noopener\" target=\"_blank\">experts<\/a> believe it is an ideal target for attacking abnormal cells.<\/p>\n<p>Unlike some personalised treatments, ZI-MA4-1 is designed as an \u201coff-the-shelf\u201d therapy that uses immune cells from donors.<\/p>\n<p>The treatment is manufactured in advance from donor cells rather than being individually tailored to each patient, with hundreds of doses produced from a single manufacturing batch.<\/p>\n<p>Experts believe this could mean advanced cell therapies are available to more patients more quickly, and at a cheaper cost.<\/p>\n<p>\u2018They\u2019ve got rid of the cancer twice but then it came back\u2019<\/p>\n<p>Mrs Tomlinson was diagnosed with ovarian cancer that had spread shortly before Christmas 2020 and immediately underwent treatment.<\/p>\n<p>By summer 2021, scans showed no evidence of disease but, a year later, the cancer returned.<\/p>\n<p>Despite further rounds of treatment and 48 chemotherapy infusions, her cancer kept coming back.<\/p>\n<p>The former Civil Service manager told the Press Association she was diagnosed as stage 3C, which means there were cancer growths spreading into the peritoneum of the body.<\/p>\n<p>She currently has a tumour between the liver and kidney as well as small tumours elsewhere.<\/p>\n<p>She said: \u201cThey\u2019ve got rid of the cancer twice but then it came back about two and a half years ago, and we\u2019ve never seemed to get rid of it since then.<\/p>\n<p><img decoding=\"async\" src=\"https:\/\/www.newsbeep.com\/uk\/wp-content\/uploads\/2026\/08\/01KYS2MNM6XZ7M2XBMCFAX7B2E.jpg\"  loading=\"lazy\" alt=\"Mrs Tomlinson was diagnosed with ovarian cancer that had spread shortly before Christmas 2020 and immediately underwent treatment\" class=\"sc-1mc30lb-0 ggpMaE inline-gallery-btn\"\/>Mrs Tomlinson was diagnosed with ovarian cancer that had spread shortly before Christmas 2020 and immediately underwent treatment (PA)<\/p>\n<p>\u201cThe chemotherapy has shrunk it but when treatment stops, it has come back.<\/p>\n<p>\u201cIt is a lot to live with and there\u2019s been ups and downs \u2013 there\u2019s been elation, there\u2019s been disappointment, and bits in between.<\/p>\n<p>\u201cBut I try very, very hard to remain very positive. Every day that I wake up is a positive. You\u2019ve got to have hope.\u201d<\/p>\n<p>Mrs Tomlinson said in her working life, she was target driven and set herself very high standards.<\/p>\n<p>\u201cBut you can\u2019t control cancer,\u201d she said. \u201cWhat I can control is how I look at it, how I deal with it, and trying to eat healthily and taking the positives in everything.<\/p>\n<p>\u201cAnd I\u2019ve learned to appreciate the smallest of things that we take for granted \u2013 and the people around you and what they mean to you.<\/p>\n<p>\u201cAlso, the beauty of outside and the trees and the colour of the trees and the birds singing.<\/p>\n<p>\u201cWe just go from A to B, don\u2019t we? Busy, busy, busy. But we never slow down and take in the wonder of what\u2019s around us.<\/p>\n<p>\u201cI often think, \u2018I\u2019m still here\u2019, and that\u2019s helped me think, \u2018Why can\u2019t I still be here in 10 years?\u2019, \u2018Why can\u2019t I still be here in 15 years?\u2019<\/p>\n<p>\u201cAnd I believe taking all the treatments offered to me is helping me kick that can a bit further down the road.<\/p>\n<p>\u201cI don\u2019t want to go anywhere. I\u2019ve still got a lot of things I want to do and things I want to achieve.\u201d<\/p>\n<p>Mrs Tomlinson said husband Paul, who she married in 2022, is her \u201crock\u201d and she is also close to her son Harry, 28.<\/p>\n<p>The Zima-101 clinical trial<\/p>\n<p>Last year, she was referred to the Christie\u2019s early phase clinical trials team for extensive screening, and learned she was a suitable candidate for the Zima-101 clinical trial.<\/p>\n<p>\u201cI decided almost straight away that I was going to go for it,\u201d she said.<\/p>\n<p><img decoding=\"async\" src=\"https:\/\/www.newsbeep.com\/uk\/wp-content\/uploads\/2026\/08\/01KYS2MKWRXKFGTR0RPWVNERJF.jpg\"  loading=\"lazy\" alt=\"Mrs Tomlinson was referred to the Christie\u2019s early phase clinical trials team for extensive screening, and learned she was a suitable candidate for the Zima-101 clinical trial\" class=\"sc-1mc30lb-0 ggpMaE inline-gallery-btn\"\/>Mrs Tomlinson was referred to the Christie\u2019s early phase clinical trials team for extensive screening, and learned she was a suitable candidate for the Zima-101 clinical trial (PA)<\/p>\n<p>\u201cThen afterwards you think, \u2018Am I doing the right thing?\u2019, because it is a little bit scary being the first person in the world to have the treatment.\u201d<\/p>\n<p>She has had three infusions of the therapy, with the option of another one depending on what scans show.<\/p>\n<p>\u201cIf it benefits me, absolutely fantastic,\u201d she said. \u201cBut if it benefits other people in the future, that\u2019s important too.<\/p>\n<p>\u201cI don\u2019t want to have gone through everything I\u2019ve gone through for nothing. I want to feel like I have made a difference.\u201d<\/p>\n<p>Professor Fiona Thistlethwaite, consultant medical oncologist at the Christie, said: \u201cWhile this is an early-stage study primarily focused on safety, it represents an exciting step forward in efforts to develop new treatment options for people like Tracy with advanced solid tumours.<\/p>\n<p>\u201cWe hope the knowledge gained will help shape future cancer treatments and ultimately improve outcomes for patients.\u201d<\/p>\n<p>Dr Jon Lim, consultant medical oncologist in advanced immunotherapy and cell therapy at the Christie, told PA: \u201cWhat\u2019s very exciting about this is that these are essentially not kind of antibody-based, but living cells.<\/p>\n<p>Main symptoms of ovarian cancer<\/p>\n<p class=\"sc-uqokbu-5 hPMytR\">NHS<\/p>\n<p>Symptoms of ovarian cancer include frequently (roughly 12 or more times a month) having:<\/p>\n<p>a swollen tummy or feeling bloated pain or tenderness in your tummy or the area between your hips (pelvic pain) no appetite or feeling full quickly after eating an urgent need to pee or needing to pee more often <\/p>\n<p>Other symptoms of ovarian cancer can include:<\/p>\n<p>indigestion constipation or diarrhoea back pain feeling tired all the time losing weight without trying unusual bleeding from the vagina, including between periods, heavier periods or after the menopause <\/p>\n<p>\u201cThese are live immune cells that are infused in hundreds of millions back to the patient, and the idea of this is that it is a little bit more targeted.<\/p>\n<p>\u201cThe reason this is very interesting is because this is the first of its kind globally in this approach, where it\u2019s taking donor immune cells, manipulating or engineering them, and putting them into the recipient.<\/p>\n<p>\u201cTracy is essentially getting somebody else\u2019s immune cells that have been engineered to \u2018see\u2019 her cancer.<\/p>\n<p>\u201cWe\u2019re very excited. This is a novel approach in the cell therapy space. We are also really showcasing what we can do in the UK.\u201d<\/p>\n<p>Namir Hassan, chief executive of Norwegian firm Zelluna, which makes ZI-MA4-1, said Mrs Tomlinson\u2019s first dose is a \u201clandmark moment\u201d, adding: \u201cIt represents the moment when years of research moved beyond the laboratory and into the clinic, offering a new potential treatment option for patients facing advanced cancers with limited alternatives.\u201d<\/p>\n<p>Only around 15 per cent of women survive ovarian cancer for five years or more after they are diagnosed.<\/p>\n<p>Dr Diana Hernandez, director of immune and advanced therapies at Anthony Nolan, said: \u201cNK cells have huge potential as off-the-shelf therapies, and this trial takes us one step closer to a wider application of engineered NK cells in the targeted treatment of cancers.<\/p>\n<p>\u201cAt Anthony Nolan we have long seen the potential of cellular therapies like this to transform the lives of patients with blood cancer.<\/p>\n<p>\u201cToday\u2019s research represents exciting progress for patients with solid tumours to benefit from these promising therapies.\u201d<\/p>\n","protected":false},"excerpt":{"rendered":"Your support helps us to tell the story From reproductive rights to climate change to Big Tech, The&hellip;\n","protected":false},"author":2,"featured_media":721904,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[10],"tags":[59,102,183719,238629,56,54,55],"class_list":["post-721903","post","type-post","status-publish","format-standard","has-post-thumbnail","category-health","tag-gb","tag-health","tag-pa2026","tag-tracy-tomlinson-treatment","tag-uk","tag-united-kingdom","tag-unitedkingdom"],"_links":{"self":[{"href":"https:\/\/www.newsbeep.com\/uk\/wp-json\/wp\/v2\/posts\/721903","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.newsbeep.com\/uk\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.newsbeep.com\/uk\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/uk\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/uk\/wp-json\/wp\/v2\/comments?post=721903"}],"version-history":[{"count":0,"href":"https:\/\/www.newsbeep.com\/uk\/wp-json\/wp\/v2\/posts\/721903\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/uk\/wp-json\/wp\/v2\/media\/721904"}],"wp:attachment":[{"href":"https:\/\/www.newsbeep.com\/uk\/wp-json\/wp\/v2\/media?parent=721903"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.newsbeep.com\/uk\/wp-json\/wp\/v2\/categories?post=721903"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.newsbeep.com\/uk\/wp-json\/wp\/v2\/tags?post=721903"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}